Court Approval of Capital Reduction

Summary by AI ^BETAClose X

Norman Broadbent plc has received the necessary Court order confirming its Capital Reduction, which is expected to become effective on or around May 6, 2026, upon registration with the Registrar of Companies. This announcement follows the company's previous disclosure and explanatory circular dated March 10, 2026, regarding the Capital Reduction.

Disclaimer*

Norman Broadbent PLC

28 April 2026

Norman Broadbent plc

Court Approval of Capital Reduction

Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, announces that it has received the requisite Court order confirming the Capital Reduction, further details of which were set out in the Company's announcement and explanatory circular, dated 10 March 2026 (the Circular).

The Capital Reduction will become effective once the Court order has been registered with the Registrar of Companies in England and Wales. The effective date of the Capital Reduction is expected to be on or around 6 May 2026.

Unless otherwise indicated all defined terms in this announcement shall have the same meaning as described in the Circular.

Contacts:

Norman Broadbent plc	Via Gracechurch Group
Kevin Davidson, CEO
Mehr Malik, CFO


Cavendish Capital Markets Limited (Nominated Adviser and Broker)	+44 (0)20 7220 0500
Julian Blunt, Seamus Fricker, Andrea Callaghan - Corporate Finance
Jasper Berry, Matt Lewis - Sales / Corporate Broking

Gracechurch Group (Financial Media & Investor Relations)	+44 (0)20 4582 3500
Murdo Montgomery	normanbroadbent@gracechurchpr.com
Tommy Bryson
Anysia Virdi

About Norman Broadbent:

Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally.

Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.

www.normanbroadbent.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END